CLINICAL TRIAL TO UNDERSTAND MEDICINAL PROPERTIES OF ASHMANTAK KNOWN AS APTA HERBAL SUTURE MATERIAL USED IN INCISED WOUND

RANDOMISED CLINICAL CONTROLLED TRIAL TO EVALUATE THE EFFICACY OF ASHMANTAK NON ABSORBABLE POLYFILAMENT SUTURE MATERIAL IN THE TREATMENT OF KSHATA VRANA - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/078178

Enrollment

Registered

2024-12-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.PATIENT WITH SIMPLE INCISED WOUND 2.PATIENT WITH SUPERFICIAL LACERETED WOUND 3.ALL PRIKRITI PATIENTS HAVING WOUND 4.PATIENT WITH HAVING WOUND APPROXIMATELY 7 CM PATIENTS WITH ROAD TRAFFIC ACCEDENTAL WOUND WITH REGULAR MARGIN

Exclusion criteria

Exclusion criteria: 1.PATIENTS WITH PENETRATING WOUND 2.PATIENTS WITH CRUSHED INJURY 3.MAJOR SURGERY PATIENTS WITH HAEMOPHILIC DISORDER

Design outcomes

Primary

Measure	Time frame
1.TO OBSERVE THE TENSILE STRENGTH OF ASHMANTAK FIBRE AT VARIOUS STAGE OF WOUND HEALING 2. TO PREPARE IT AN ACCEPTABLE HERBAL SUTURING MATERIAL AND STUDY ITS PROPERTIES 3.TO DETERMINE DIAMETER OF ASHMANTAK FIBRETimepoint: 0TH , 2ND DAY , 4TH DAY , 6TH DAY , 8TH DAY , 10NTH DAY	—

Secondary

Measure	Time frame
1.TO OBSERVE HAEMOSTATIC PROPERTY OF ASHMANTAK 2. TO OBSERVE THE MERIT AND DEMERIT AS SUTURING MATERIAL AND COMPARE WITH ETHILON 3.0Timepoint: 0TH , 2ND DAY , 4TH DAY , 6TH DAY , 8 TH DAY , 10 TH DAY	—

Countries

India

Contacts

Public ContactVD AKBAR WALANDKAR

HON SHRI ANNASAHEB DANGE AYURVED MEDICAL COLLEGE POST GRADUATE AND RESEARCH CENTER ASHTA

akbar.walandkar@gmail.com9860181980

Outcome results